Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(5%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_1
1
5%
Ph phase_2
5
25%
Ph phase_4
8
40%
Ph phase_3
4
20%

Phase Distribution

1

Early Stage

5

Mid Stage

12

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
5(27.8%)
Phase 3Large-scale testing
4(22.2%)
Phase 4Post-market surveillance
8(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

20

all time

Status Distribution
Active(2)
Completed(10)
Terminated(2)
Other(6)

Detailed Status

Completed10
unknown6
Withdrawn2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.6%)
Phase 25 (27.8%)
Phase 34 (22.2%)
Phase 48 (44.4%)

Trials by Status

completed1050%
recruiting15%
not_yet_recruiting15%
withdrawn210%
unknown630%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07687160Phase 4

SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy

Not Yet Recruiting
NCT03264352Phase 4

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Recruiting
NCT04692467Phase 2

Treatment of Early Hypertension Among Persons Living With HIV in Haiti

Completed
NCT02368665Phase 3

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Completed
NCT04954196Phase 2

Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index

Withdrawn
NCT05165251Phase 4

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Unknown
NCT04474899Phase 4

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension

Unknown
NCT03666351Phase 4

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

Completed
NCT04554303

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Unknown
NCT03978884Phase 4

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes

Withdrawn
NCT02651870Phase 3

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Completed
NCT03489317

Gut Microbiomes in Patients With Metabolic Syndrome

Unknown
NCT02944734Phase 2

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Completed
NCT02586311Phase 3

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Completed
NCT02548286Phase 1

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

Completed
NCT02206165Phase 2

A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension

Unknown
NCT01103960Phase 3

An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

Completed
NCT02059616Phase 2

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Unknown
NCT00819104Phase 4

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

Completed
NCT00426478Phase 4

Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20